Encompass Health Co. (NYSE:EHC) Stake Lifted by Globeflex Capital L P

Globeflex Capital L P lifted its position in Encompass Health Co. (NYSE:EHC - Free Report) by 305.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 42,739 shares of the company's stock after buying an additional 32,200 shares during the quarter. Globeflex Capital L P's holdings in Encompass Health were worth $3,947,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. MassMutual Private Wealth & Trust FSB lifted its holdings in shares of Encompass Health by 87.8% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock valued at $27,000 after purchasing an additional 137 shares during the last quarter. Avior Wealth Management LLC purchased a new stake in Encompass Health in the third quarter valued at approximately $40,000. Tompkins Financial Corp acquired a new stake in shares of Encompass Health in the fourth quarter valued at approximately $46,000. V Square Quantitative Management LLC grew its position in shares of Encompass Health by 43.8% during the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock worth $54,000 after acquiring an additional 177 shares during the last quarter. Finally, Morse Asset Management Inc acquired a new position in shares of Encompass Health in the 3rd quarter valued at $68,000. Institutional investors and hedge funds own 97.25% of the company's stock.

Analyst Ratings Changes

Several brokerages have issued reports on EHC. William Blair reissued an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. Barclays boosted their price target on Encompass Health from $116.00 to $118.00 and gave the company an "overweight" rating in a research report on Friday, February 7th. Royal Bank of Canada reiterated an "outperform" rating and issued a $110.00 target price on shares of Encompass Health in a research note on Tuesday, February 11th. KeyCorp upped their price target on Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a research note on Monday, February 10th. Finally, StockNews.com raised shares of Encompass Health from a "hold" rating to a "buy" rating in a research note on Saturday, February 15th. Ten research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Buy" and an average price target of $107.67.

Remove Ads

Insider Buying and Selling at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of the company's stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the sale, the chief accounting officer now directly owns 69,164 shares of the company's stock, valued at approximately $6,798,129.56. This represents a 6.79 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 2.10% of the stock is currently owned by corporate insiders.

Encompass Health Stock Up 1.5 %

Encompass Health stock traded up $1.46 during midday trading on Wednesday, hitting $99.10. 513,766 shares of the company were exchanged, compared to its average volume of 632,270. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. Encompass Health Co. has a fifty-two week low of $76.11 and a fifty-two week high of $104.55. The company's fifty day moving average price is $97.60 and its 200-day moving average price is $97.05. The company has a market cap of $9.98 billion, a PE ratio of 22.22, a price-to-earnings-growth ratio of 2.31 and a beta of 0.92.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, beating analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. On average, research analysts predict that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be issued a dividend of $0.17 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.68 annualized dividend and a yield of 0.69%. Encompass Health's dividend payout ratio is presently 15.25%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.